PMC:6218602 / 72153-73169 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6218602","sourcedb":"PMC","sourceid":"6218602","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6218602","text":"Treatment resistance in schizophrenia continues to be a therapeutic challenge in psychiatry. Within the spectrum of the disease, neural circuits within specific brain regions and their structural and functional links to corresponding regions seem to be further disrupted in TRS. In this review, we have examined TRS from a circuit-based perspective. We highlighted attempts by leading schizophrenia clinicians and researchers to standardize the definition of treatment resistance in schizophrenia and have identified and incorporated recommended terminology with regards to the clinical sub-specifiers or symptom phenotypes that are common to TRS. We discussed the developments of network-based science from the early pioneers who recognized psychiatric illness and schizophrenia as a disease of neuronal and functional disconnectivity. With the development of neuroimaging methods, modern-day connectionists have built upon these theories and have continued to develop and advance network connectomic science today.","tracks":[]}